ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
W.a.g Payment Solutions Plc

W.a.g Payment Solutions Plc (WPS)

81.40
1.40
(1.75%)
Closed January 05 11:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
81.40
Bid
81.20
Ask
81.40
Volume
248,104
80.20 Day's Range 81.60
61.00 52 Week Range 95.00
Market Cap
Previous Close
80.00
Open
81.60
Last Trade Time
Financial Volume
200,972p
VWAP
81.003
Average Volume (3m)
227,283
Shares Outstanding
689,471,537
Dividend Yield
-
PE Ratio
-12.27
Earnings Per Share (EPS)
-0.07
Revenue
2.09B
Net Profit
-45.64M

About W.a.g Payment Solutions Plc

Sector
Business Services, Nec
Industry
Business Services, Nec
Headquarters
London, Gbr
Founded
-
W.a.g Payment Solutions Plc is listed in the Business Services sector of the London Stock Exchange with ticker WPS. The last closing price for W.a.g Payment Solutions was 80p. Over the last year, W.a.g Payment Solutions shares have traded in a share price range of 61.00p to 95.00p.

W.a.g Payment Solutions currently has 689,471,537 shares outstanding. The market capitalization of W.a.g Payment Solutions is £551.58 million. W.a.g Payment Solutions has a price to earnings ratio (PE ratio) of -12.27.

WPS Latest News

Eurowag Total Voting Rights

Eurowag 31 December 2024   31 December 2024   W.A.G. payment solutions plc (the "Company" or "Eurowag")   Total Voting Rights   For the purposes of the Financial Conduct Authority's Disclosure...

Eurowag Total Voting Rights

Eurowag 29 November 2024   29 November 2024   W.A.G. Payment Solutions plc (the "Company" or "Eurowag")   Total Voting Rights   For the purposes of the Financial Conduct Authority's Disclosure...

Eurowag Doc re. Block Listing Application

Eurowag 31 October 2024     W.A.G payment solutions plc (the "Company" or "Eurowag")   31 October 2024   Block Listing of Shares The Company announces that an application has been made to the...

Eurowag confident in future as revenue rises solidly

WAG Payment Solutions PLC on Thursday reported sound revenue growth, as the number of average active payment solution ...

Eurowag Trading Update

Eurowag 24 October 2024   24 October 2024     W.A.G payment solutions plc   ("Eurowag" or the "Group") Trading Update   Continued strong performance, platform phased rollout on-track Q4 2024...

EXTRA: Eurowag CEO sets sight on European expansion and growth

The head of WAG Payment Solutions PLC on Thursday said its new platform will deliver customer growth and greater cros ...

Eurowag revenue jumps double digits in first half while profit wanes

WAG Payment Solutions PLC on Thursday posted mixed financial results for the first half with greater expenses hamperi ...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
13.44.358974358977883785180279.94777422DE
4-1.6-1.927710843378384.2787246080.58878347DE
12-1.8-2.1634615384683.287.874.822728381.15654464DE
2619.431.29032258066287.86120764677.89947156DE
52-4.6-5.348837209386956119054374.47081286DE
156-14-14.675052410995.41096131856983.22369722DE
260-53.6-39.70370370371351606133188088.46285754DE

WPS - Frequently Asked Questions (FAQ)

What is the current W.a.g Payment Solutions share price?
The current share price of W.a.g Payment Solutions is 81.40p
How many W.a.g Payment Solutions shares are in issue?
W.a.g Payment Solutions has 689,471,537 shares in issue
What is the market cap of W.a.g Payment Solutions?
The market capitalisation of W.a.g Payment Solutions is GBP 551.58M
What is the 1 year trading range for W.a.g Payment Solutions share price?
W.a.g Payment Solutions has traded in the range of 61.00p to 95.00p during the past year
What is the PE ratio of W.a.g Payment Solutions?
The price to earnings ratio of W.a.g Payment Solutions is -12.27
What is the cash to sales ratio of W.a.g Payment Solutions?
The cash to sales ratio of W.a.g Payment Solutions is 0.27
What is the reporting currency for W.a.g Payment Solutions?
W.a.g Payment Solutions reports financial results in EUR
What is the latest annual turnover for W.a.g Payment Solutions?
The latest annual turnover of W.a.g Payment Solutions is EUR 2.09B
What is the latest annual profit for W.a.g Payment Solutions?
The latest annual profit of W.a.g Payment Solutions is EUR -45.64M
What is the registered address of W.a.g Payment Solutions?
The registered address for W.a.g Payment Solutions is THIRD FLOOR (EAST), ALBEMARLE HOUSE, 1 ALBEMARLE STREET, LONDON, W1S 4HA
What is the W.a.g Payment Solutions website address?
The website address for W.a.g Payment Solutions is www.investors.eurowag.com
Which industry sector does W.a.g Payment Solutions operate in?
W.a.g Payment Solutions operates in the BUSINESS SERVICES, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
devil dog 96 devil dog 96 1 minute ago
Tell everyone why you think they never took the 39 million shares off restriction if they need shares to dump? Why have they not taken 1 share off restriction since early 2021 if they need shares to dump?? Why would they issue new shares that will be unregistered and also have to wait a year before
ATMH
CrossFireTrader CrossFireTrader 1 minute ago
Page 22 of 26, and If say I'm Bullish that'll set 280e off, and I'll  be accused of pumping our little lottery ticket. I'm here for the long haul. I'm not here to sell at 0.016 or 0.02 or 0.03 or whatever his new price is. He actually likes GDVM a lot more than he lets on. Since you seem to be somew
GDVM
Mr. Bill Mr. Bill 5 minutes ago
https://measuringmyhealth.com/what-is-a-normal-pi-on-a-pulse-oximeter/
georgejjl georgejjl 5 minutes ago
That is WRONG. The current standard of care is donepezil (Aricept) and memantine, etc.

MAB's still are an extremely small number of treatments for Alzheimer's in the USA and worldwide.

Good luck and GOD bless,
AVXL
axelvento axelvento 25 minutes ago
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 28 minutes ago
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 29 minutes ago
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 29 minutes ago
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 30 minutes ago
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 32 minutes ago
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 33 minutes ago
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 34 minutes ago
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 35 minutes ago
Probably
AVXL
HokieHead HokieHead 37 minutes ago
Wrong..
TWOH
HokieHead HokieHead 37 minutes ago
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 39 minutes ago
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 40 minutes ago
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 41 minutes ago
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 41 minutes ago
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 42 minutes ago
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 43 minutes ago
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 43 minutes ago
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM
Steady_T Steady_T 46 minutes ago
MABS are the current standard of care, so Blarcamesine has to be better than the MABS, which is not saying much.

I suspect that if Blarcamesine was the equal of the MABS is would still be approved on safety and cost grounds.

As has been pointed out multiple times on the
AVXL

Your Recent History

Delayed Upgrade Clock